Physician profile
David Weithorn
NPI 1033504303
$6,581.85
in general payments reported to CMS, 2019-2025
9 companies · $399 in 2025
The $399 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.69 · 2020: $1,230 · 2021: $148 · 2022: $48.11 · 2023: $4,037 · 2024: $694 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $1,040 · Education: $90.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $1,039.52 |
| Education | $90.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,556.25 | 2021-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Allergan, INC. | $1,203.58 | 2020 | |
| Medtronic, INC. | $481.62 | 2024-2025 | Signia, Rapidvac, Transorb |
| Virtual Incision Corporation | $161.00 | 2024 | Mira |
| Davol INC. | $52.26 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $48.11 | 2022 | |
| Becton, Dickinson and Company | $32.15 | 2025 | |
| Novo Nordisk INC | $24.71 | 2024 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $22.17 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weithorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.